GlaxoSmithKline has set up its eighth R&D Centre of Excellence which will focus on building partnerships with biotech firms, academia …
The ABPI has welcomed a new report on the ethics of animal research, agreeing the industry must challenge the need …
Pharmaceutical companies should increase their investment in community pharmacists, according to a leading pharmacy spokesperson.Michael Holden, NHS development manager at …
Five years into the programme of reforms started with the NHS Plan, attention has turned to the services provided by …
Pfizer looks set to become a serious contender in oncology with its promising phase III kidney cancer drug Sutent.Until now …
Pharma and biotech companies presented a welter of data at this year's ASCO cancer conference, highlighting the growing importance of …
Global procurement processes don't deliver best value and are frequently flawed, according to speakers at the Pharmaceutical Society's annual Question …
Shire Pharmaceuticals hopes to strengthen its ADHD portfolio and establish itself in the global gastrointestinal market with a number of …
AstraZeneca has made a key appointment to its global PR for its statin brand Crestor.Ben Strutt spent six years as …
Roche has raised its full-year sales forecast after strong first quarter results saw the Swiss company outperform a number of …
The monoclonal antibody market will treble in size to $30 billion by 2010, according to a report by analysts Datamonitor.Datamonitor …
A new treatment for the rare and difficult to treat condition of chronic iron overload has been filed by Novartis …
GlaxoSmithKline's Requip has become the first medicine to receive US approval for the treatment of restless legs syndrome (RLS), after …
Pfizer will cut costs worth $4 billion over the next three years in an attempt to return to double-digit earnings …